Istanbul, Turkey

Elif Keskin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,812 
Other
 patents

Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elif Keskin: Innovator in Neurodegenerative Disease Treatment

Introduction

Elif Keskin is a prominent inventor based in Istanbul, Turkey. She has made significant contributions to the field of neurodegenerative diseases, particularly in the treatment of Parkinson's disease. Her innovative work has led to the development of novel drug molecules that hold promise for improving patient outcomes.

Latest Patents

Elif Keskin holds a patent for "Heterobivalent ligands suitable for use in the treatment of Parkinson's disease." This patent discloses novel drug molecules and their use in treating neurodegenerative diseases, such as Parkinson's disease. Her research focuses on creating effective therapeutic options for patients suffering from these debilitating conditions.

Career Highlights

Throughout her career, Elif has demonstrated a strong commitment to advancing medical science. Her work has not only contributed to the understanding of neurodegenerative diseases but has also paved the way for potential new treatments. With her innovative approach, she continues to inspire others in the field of medical research.

Collaborations

Elif has collaborated with notable colleagues, including Özge Sensoy and Mustafa Güzel. These partnerships have enhanced her research efforts and contributed to the development of her groundbreaking patent.

Conclusion

Elif Keskin is a trailblazer in the field of neurodegenerative disease treatment, with her innovative patent showcasing her dedication to improving patient care. Her contributions are vital in the ongoing fight against Parkinson's disease and highlight the importance of research in developing effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…